Evidence map›Paper›PMID 12426391›Full record

ArticleThe EMBO journal2002

Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch.

Victor C Hou, Robert Lersch, Sherry L Gee, Julie L Ponthier, Annie J Lo, Michael Wu, Chris W Turck, Mark Koury, Adrian R Krainer, Akila Mayeda and 1 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The EMBO journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. RNA splicing during terminal erythropoiesis.Current opinion in hematology · 2017
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Victor C HouLife Sciences Division, Lawrence Berkeley National Laboratory, University of California at Berkeley, Berkeley, CA 94720, USA.
Robert Lersch
Sherry L Gee
Julie L Ponthier
Annie J Lo
Michael Wu
Chris W Turck
Mark Koury
Adrian R Krainer
Akila Mayeda
John G Conboy
Lawrence Berkeley National Laboratory · USCold Spring Harbor Laboratory · USUniversity of California, Berkeley · USUniversity of California, San Francisco · USUniversity of Miami · USVanderbilt University Medical Center · US

Funding

VIRAL TRANSACTIVATIONP01CA013106 · NCI · COLD SPRING HARBOR LABORATORY · PI Camila dos Santos · 1985 to 2026
$116.8M
RED CELL BAND 41--DEVELOPMENTAL CHANGES IN RNA SPLICINGR01HL045182 · NHLBI · UNIVERSITY OF CALIFORNIA BERKELEY · PI CONBOY, JOHN G · 1990 to 2010
$4.8M
Red Cell Band 4.1 - Developmental Changes in RNA SplicingR56HL045182 · NHLBI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI CONBOY, JOHN G · 2008 to 2008
$500k
NCI NIH HHS CA 13106NCI NIH HHS P01 CA013106NHLBI NIH HHS HL 45182NHLBI NIH HHS R01 HL045182NHLBI NIH HHS R56 HL045182
6 · The paper itself

Abstract

A physiologically important alternative pre-mRNA splicing switch, involving activation of protein 4.1R exon 16 (E16) splicing, is required for the establishment of proper mechanical integrity of the erythrocyte membrane during erythropoiesis. Here we identify a conserved exonic splicing silencer element (CE(16)) in E16 that interacts with hnRNP A/B proteins and plays a role in repression of E16 splicing during early erythropoiesis. Experiments with model pre-mRNAs showed that CE(16) can repress splicing of upstream introns, and that mutagenesis or replacement of CE(16) can relieve this inhibition. An affinity selection assay with biotinylated CE(16) RNA demonstrated specific binding of hnRNP A/B proteins. Depletion of hnRNP A/B proteins from nuclear extract significantly increased E16 inclusion, while repletion with recombinant hnRNP A/B restored E16 silencing. Most importantly, differentiating mouse erythroblasts exhibited a stage-specific activation of the E16 splicing switch in concert with a dramatic and specific down-regulation of hnRNP A/B protein expression. These findings demonstrate that natural developmental changes in hnRNP A/B proteins can effect physiologically important switches in pre-mRNA splicing.

Indexed as

Alternative SplicingCytoskeletal ProteinsGene SilencingMembrane ProteinsNeuropeptidesRegulatory Sequences, Nucleic AcidAnimalsBase SequenceConsensus SequenceErythroid Precursor CellsErythropoiesisExonsGene Expression RegulationHeLa CellsHeterogeneous-Nuclear Ribonucleoprotein Group A-BHumansCytoskeletal Proteinserythrocyte membrane band 4.1 proteinerythrocyte membrane protein band 4.1-like 1Heterogeneous-Nuclear Ribonucleoprotein Group A-BMembrane ProteinsNeuropeptidesProteinsRNA-Binding ProteinsRNA Precursors

Identifiers

PMID12426391
PMCPMC137214
OpenAlexW2001645066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.